Rheumatoid Arthritis

Rheumatoid Arthritis | Pharmacor | G7 | 2015

Last Updated 15 December 2014
Tumor necrosis factor (TNF)-α inhibitors continue to dominate the multibillion-dollar rheumatoid arthritis (RA) market. An increase in the prevalent RA population,…

Rheumatoid Arthritis | Pharmacor | G7 | 2014

Last Updated 15 December 2014
Tumor necrosis factor (TNF)-α inhibitors continue to dominate the multibillion-dollar rheumatoid arthritis (RA) market. An increase in the prevalent RA population,…

Rheumatoid Arthritis | Chart Trends | US | 2014

The Rheumatoid Arthritis (RA) treatment paradigm continues to evolve as new therapeutic options are added to physicians’ toolkits. The positioning of newer agents (e.g., Pfizer’s Xeljanz,…